Astera Labs, Inc. ALAB
364.62
4.11
1.14%
as of 25 Sep
- Market cap
- $63.7B
- P/E
- 168×
Follow ALAB
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
18.40% | 18.82% | 21.11% | 25.83% | |
| 16.68% | 16.95% | 19.25% | 23.07% | ||
ROIC |
48.53% | 62.00% | 45.23% | 36.15% | |
Return on Tangible Assets |
15.76% | 16.59% | 19.32% | 22.99% | |
Average Days of Receivables |
21.66 | 35.62 | 49.13 | 58.45 | |
Free Cash Flow per Share |
1.37 | 1.69 | 2.01 | 1.61 | |
Free Cash Flow |
229.44 | 281.76 | 342.81 | 276.68 | |
Capital Expenditures |
(34.30) | (37.54) | (40.59) | (59.04) | |
Piotroski F-Score |
5.00 | 5.00 | 6.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
10.96% | 12.51% | 14.31% | 11.27% | |
Accounts Receivable Turnover |
21.18 | 13.97 | 9.79 | 11.09 | |
Accounts Payable Turnover |
8.02 | 5.98 | 5.64 | 6.99 | |
Inventory Turnover |
4.67 | 4.06 | 4.32 | 3.47 | |
Average Days of Payables |
52.99 | 74.60 | 84.73 | 65.85 | |
Days of Inventory on Hand |
106.06 | 103.86 | 91.31 | 138.93 | |
Tax Rate |
0.33 | 0.00 | (0.01) | 0.15 | |
Research and Development Expense of Revenue |
36.89% | 35.66% | 36.46% | 36.13% | |
Selling, General and Administrative Expense of Revenue |
23.77% | 19.69% | 17.17% | 16.25% | |
Share Based Compensation of Revenue |
23.08% | 18.77% | 16.63% | 16.23% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.33 | 1.46 | 1.43 | 0.91 | |
Depreciation/Fixed assets |
(0.07) | (0.01) | 0.03 | 0.05 | |
Capex/Depreciation |
7.11 | 34.04 | (14.38) | (9.33) | |
Revenue per Share |
4.32 | 5.12 | 5.87 | 6.97 | |
Operating CF per Share |
1.58 | 1.92 | 2.25 | 1.95 | |
Capex per Share |
(0.20) | (0.23) | (0.24) | (0.34) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.05 | |
Net Profit Margin |
27.50% | 25.70% | 26.72% | 30.74% |
Columns are period end dates